Colin Carrie on Questions Passed as Orders for Returns

With regard to the clinical trials conducted on COVID-19 vaccine effectiveness, specifically those pertaining to the widely distributed vaccines by Pfizer/BioNTech and Moderna that Health Canada reviewed, vaccine mandates, and vaccination campaigns: (a) how many trial participants contracted COVID-19, broken down by participants in the experimental and control groups, versus the total number of participants; (b) why was the information in (a), necessary for ascertaining the absolute risk reduction of acquiring COVID-19 following vaccination, not communicated to the general public to enable a more realistic assessment of health risks in support of informed consent; (c) did any trial protocol deviations occur in trial participants who contracted COVID-19; (d) was the government aware that the clinical trials did not test the ability of the vaccines to stop viral transmission before implementing the federal vaccination policy for government employees, whose stated objectives include the protection of these employees as well as their colleagues and clients from COVID-19; (e) if the answer to (d) is affirmative, what was the justification to mandate relatively healthy government employees to get vaccinated against SARS-CoV-2; (f) who made the decision to implement the policy in (d); and (g) how does the government justify its continued campaigns to encourage vaccination in relatively healthy Canadians, starting as young as 6 months?